National Health Investors Stock Return On Asset
| WX6 Stock | 72.50 0.50 0.69% |
National Health Investors fundamentals help investors to digest information that contributes to National Health's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Health stock.
National |
National Health Investors Company Return On Asset Analysis
National Health's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, National Health Investors has a Return On Asset of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Return On Asset (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
National Fundamentals
| Current Valuation | 3.32 B | |||
| Price To Book | 1.82 X | |||
| Price To Sales | 8.98 X | |||
| Revenue | 278.19 M | |||
| EBITDA | 178.82 M | |||
| Net Income | 66.4 M | |||
| Total Debt | 1.15 B | |||
| Cash Flow From Operations | 185.34 M | |||
| Market Capitalization | 2.24 B | |||
| Total Asset | 2.51 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.09 % | |||
| Net Asset | 2.51 B |
About National Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Health Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for National Stock Analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.